✦ LIBER ✦

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

✍ Scribed by Pentheroudakis, George; Kotoula, Vassiliki; Fountzilas, Elena; Kouvatseas, George; Basdanis, George; Xanthakis, Ioannis; Makatsoris, Thomas; Charalambous, Elpida; Papamichael, Demetris; Samantas, Epaminontas; Papakostas, Pavlos; Bafaloukos, Dimitrios; Razis, Evangelia; Christodoulou, Christos; Varthalitis, Ioannis; Pavlidis, Nicholas; Fountzilas, George

Book ID: 121541555
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 330 KB
Volume: 14
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-14-111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel plus cisplatin and bevacizumab

Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group

✍ N. Kentepozidis, A. Kotsakis, A. Soultati… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 214 KB

Chemotherapy with gemcitabine, cisplatin

Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

✍ Ioannis Boukovinas; Nikolaos Androulakis; Nikolaos Kentepozidis; Aris Polyzos; P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 218 KB

Pegylated liposomal doxorubicin in combi

Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study

✍ Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Kos 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 292 KB